期刊文献+

Transitional cell carcinoma associated with aristolochic acid nephropathy: most common cancer in chronic hemodialysis patients in China 被引量:4

Transitional cell carcinoma associated with aristolochic acid nephropathy: most common cancer in chronic hemodialysis patients in China
原文传递
导出
摘要 Background The research of cancer in patients on hemodialysis (HD) in China has not been reported. The aim of this study was to investigate the clinical and histological features and outcomes of cancer in Chinese HD patients. Methods The study subjects were 49 cancer patients (1.4%) out of 3448 end stage renal disease (ESRD) patients maintained on HD at China-Japan Friendship Hospital from October 1997 to July 2011. Results Urinary tract cancer (74%) was the most common followed by gastrointestinal tract cancer (12%), breast cancer (6%), lung cancer (4%), thyroid cancer (2%), and hematologic cancer (2%). Thirty-three patients (67%) had urinary tract transitional cell carcinoma (TCC) and 29 of them had aristolochic acid nephropathy (AAN) as underlying disease. Death occurred in eight patients out of 49, and the survival rate of HD patients with cancer was similar to those without cancer (P=0.120). Conclusion The urinary tract TCC is the most common cancer in HD patients with AAN in one of the centers of northern China. Background The research of cancer in patients on hemodialysis (HD) in China has not been reported. The aim of this study was to investigate the clinical and histological features and outcomes of cancer in Chinese HD patients. Methods The study subjects were 49 cancer patients (1.4%) out of 3448 end stage renal disease (ESRD) patients maintained on HD at China-Japan Friendship Hospital from October 1997 to July 2011. Results Urinary tract cancer (74%) was the most common followed by gastrointestinal tract cancer (12%), breast cancer (6%), lung cancer (4%), thyroid cancer (2%), and hematologic cancer (2%). Thirty-three patients (67%) had urinary tract transitional cell carcinoma (TCC) and 29 of them had aristolochic acid nephropathy (AAN) as underlying disease. Death occurred in eight patients out of 49, and the survival rate of HD patients with cancer was similar to those without cancer (P=0.120). Conclusion The urinary tract TCC is the most common cancer in HD patients with AAN in one of the centers of northern China.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2012年第24期4460-4465,共6页 中华医学杂志(英文版)
关键词 aristolochic acid nephropathy end stage renal disease HEMODIALYSIS transitional cell carcinoma urinary tract aristolochic acid nephropathy end stage renal disease hemodialysis transitional cell carcinoma urinary tract
  • 相关文献

参考文献1

二级参考文献11

  • 1Mochly-Rosen D,Khaner H,Lopez J.Identification of intracellular receptor proteins for activated protein kinase C.Proc Nail Acad Sci U S A,1991,88:3997-4000.
  • 2Ran D,Jiang Z,Yao L,et al.Coordinated movement of rackl with activated betaiipkc.J Biol Chem,1999,274:27039-27046.
  • 3Chang BY,Harte RA,Cartwright CA.RACK1:a novel substrate for the Src protein-tyrosine kinase.Oncogene,2002,21:7619-7629.
  • 4Wang Z,Jiang L,Huang C,et al.Comparative proteomics approach to screening of potential diagnostic and therapeutic targets for oral squamous cell carcinoma.Mol Cell Proteomics,2008,7:1639-1650.
  • 5Wang Z,Zhang B,Jiang L,et al.RACK1,an excellent predictor for poor clinical outcome in oral squamous carcinoma,similar to Ki67.Eur J Cancer,2009,45:490-496.
  • 6Egidy G,Jule S,Bosse P,et al.Transcription analysis in the MeLiM swine model identifies RACK1 as a potential marker of malignancy for human melanocytic proliferation.Mol Cancer,2008,7:34.
  • 7Nagashio R,Sato Y,Matsumoto T,et al.Expression of RACK1 is a novel biomarker in pulmonary adenoeareinomas.Lung Cancer,2010,69:54-59.
  • 8Can XX,Xu JD,Liu XL,et al.Raekl:a superior independent predictor for poor clinical outcome in breast cancer.Int J Cancer,2010,127:1172-1179.
  • 9A1-Reefy S,Mokbel K.The role of RACK1 as an independent prognostic indicator in human breast cancer.Breast Cancer Res Treat,2010,123:911 ; author reply 2.
  • 10Mamidipudi V,Zhang J,Lee KC,et al.RACK1 regulates G1/Sprogression by suppressing Src kinase activity.Mol Cell Biol,2004,24:6788-6798.

共引文献2

同被引文献11

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部